The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

The Chinese vaccine is one of two that the Brazilian government has lined up A coronavirus vaccine developed by China's Sinovac has been found to be 50.4% effective in Brazilian clinical trials ...

The Himalayan nation of Nepal is all set to destroy four million doses of the Sinovac COVID-19 vaccine, procured from China in April 2021, according to a report in Epardafas. Sinovac's destruction ...

China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion. According to press ...

This report presents two cases of TTP occurring after the administration of the inactivated vaccine CoronaVac from Sinovac ...

Children in this age group will be able to receive the German-manufactured vaccine from February 16, while the Chinese-made Sinovac version is already available to them. However, only 19,245 ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

The Chilean government bet big on Sinovac’s Covid-19 vaccine, part-funding along with local businesses CoronaVac’s trial in the country, and in 2021 ordered 60 million doses of the drug over ...

Chinese vaccine producers Sinovac and Sinopharm have signed on to global vaccine sharing scheme Covax, which aims to distribute vaccines to poorer countries. The Global Alliance for Vaccines and ...

“Sometime in the night of Feb 25 and morning of 26 Feb, we will be receiving 192,000 doses of the Sinovac jab ... doses of the US/German Pfizer vaccine. The president said the campaign takes ...

Which vaccines could pose a problem for border crossings? Those who have been immunized with the Chinese Sinovac, CanSino or Russian Sputnik vaccines should be aware that there is a high probability ...

A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac Biotech and immune thrombotic thrombocytopenic purpura ...